Skip to main content
Frontiers in Oncology logoLink to Frontiers in Oncology
. 2021 Aug 31;11:738970. doi: 10.3389/fonc.2021.738970

Retraction: RBFOX3 Promotes Gastric Cancer Growth and Progression by Activating HTERT Signaling

Frontiers Editorial Office1,*
PMCID: PMC8439277  PMID: 34532292

The journal retracts the 20 July 2020 article cited above.

Following publication, concerns were raised regarding the integrity of the images in the published figures. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies.

This retraction was approved by the Chief Editors of Frontiers in Oncology and the Chief Executive Editor of Frontiers. The authors did not agree to this retraction.


Articles from Frontiers in Oncology are provided here courtesy of Frontiers Media SA

RESOURCES